Logged in as: Guest
WCN'24 Home
View detailed Congress Program
View Program at a glance
LOGIN
TOTALLY HARMLESS OR SLOW BURN: HOW DO WE INTERPRET CHANGES IN SERUM CREATININE FROM MOLECULARLY-TARGETED CANCER THERAPIES?
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/cccea295775b318a0064b3cef6a6f42c.pdf
Abstract Title
TOTALLY HARMLESS OR SLOW BURN: HOW DO WE INTERPRET CHANGES IN SERUM CREATININE FROM MOLECULARLY-TARGETED CANCER THERAPIES?
First Name *
Susan
Last Name *
Ziolkowski
Co-author 1
Jin Long jinlong@stanford.edu Stanford University Pediatrics (Nephrology) Palo Alto, CA
Co-author 2
Yutong Zhong yutongzh@stanford.edu Stanford University Pediatrics (Nephrology) Palo Alto, CA
Co-author 3
Shuchi Anand sanand2@stanford.edu Stanford University Medicine (Nephrology) Palo Alto, CA
Co-author 4
Co-author 5
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
